FTCI
RANI

Quiroga Cortes Isidoro Alfonso

Known title: 10% OwnerCIK: 0001854578

Quiroga Cortes Isidoro Alfonso's purchase track record

How the stock did after each of Quiroga Cortes Isidoro Alfonso's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
5
of 5 since June 10, 2022
Stock higher 6 months later
40%
3 months: 40%
Median 6-month return
-22.0%
3 months: -9.7%
Beat the S&P 500
40%
median -29.6% vs. index
PurchaseStockAmount3 months6 months
8/20/2024FTCI$8K+43.9%+22.7%
8/12/2024FTCI$316K+146.9%+61.6%
12/30/2022RANI$51K-12.5%-30.2%
10/31/2022RANI$387K-9.7%-22.0%
6/10/2022FTCI$149K-18.4%-50.1%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

FTC Solar Partners with Linxon and Hitachi Energy for North America Projects. FTC Solar has announced a strategic collaboration with Linxon and Hitachi Energy to develop utility-scale renewable energy and grid infrastructure in North America. The agreement focuses on supplying solar and battery energy storage systems. This partnership aims to accelerate project execution and expand the company's presence in the region.

this person other insiders at FTCI

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 5, 2026

RANI joins FDA Emerging Technology Platform. Rani Therapeutics was added to the FDA’s Emerging Technology Platform, a program that highlights innovative medical technologies. The inclusion signals that the FDA sees potential in the company’s approach and may facilitate future regulatory interactions. This development comes as the stock is trading near its recent support level.

this person other insiders at RANI

Transaction History

FTCI▲ Buy$8K
FTCI▲ Buy$40K
FTCI▲ Buy$50K
FTCI▲ Buy$25K
FTCI▲ Buy$1K
FTCI▲ Buy$80K
FTCI▲ Buy$9K
FTCI▲ Buy$110K
FTCI▲ Buy$0
RANI▼ Sell$10.6M
FTCI▲ Buy$0
FTCI▲ Buy$50K
RANI▲ Buy$51K
RANI▲ Buy$105K
RANI▲ Buy$159K
RANI▲ Buy$23K
RANI▲ Buy$101K
FTCI▲ Buy$0
FTCI▲ Buy$149K

We use analytics to understand how market-wall is used. No personal data is sold.